JORGENSEN NATHAN D. (Chief Financial Officer) received a stock award from VOYAGER THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/24/2025ACC: 0001104659-25-016510
Officer· Chief Financial Officer
Since Feb 2026
+154.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
154.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+51.50K
Price / share
—
Trade value
—
% of position
64.4%
2/21/2025
80K→131.50K
Total
Net shares
+51.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2025 | A · Award | +51.50K | — | — | 64.4% | 80K | 131.50K |
| Total | +51.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
103K shares
Shares
+103K
Strike price
4.22
Held after
103K
Exercisable
—
2/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock103K shares | 2/21/2025 | A · Award | +103K | 4.22 | — | 103K |